Obama Tax Plan Delivers Softer Blow Than Expected
This article was originally published in The Tan Sheet
Executive Summary
The Obama administration's proposal to close a tax loophole for U.S. multinational firms would not have as large an impact as some pharmaceutical companies feared
You may also be interested in...
“High-Quality” Skin Care, Listerine Lead J&J Consumer Sales
Johnson & Johnson's skin care business globally and oral care unit in foreign markets helped offset sales declines of OTCs and nutritionals in the consumer business during the first quarter
Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.
Track-And-Trace: With Deadline a Year Away, Some Lessons from Early Adopters
EMD Serono has been tracking Serostim packages since 2002; J&J is using Prezista 600 mg as a trial run for serialization.